Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $213.9900 (1.02%) ($213.9900 - $213.9900) on Tue. Nov. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.78% (three month average) | RSI | 48 | Latest Price | $213.9900(1.02%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -0.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IGOV(25%) IWF(21%) XLK(19%) VUG(18%) TLT(12%) | Factors Impacting SGEN price | SGEN will decline at least -0.39% in a week (0% probabilities). ACES(-48%) XLE(-89%) VXX(-52%) ONLN(-47%) REMX(-45%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.39% (StdDev 0.78%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $212.57(0.67%) | 10 Day Moving Average | $213.03(0.45%) | 20 Day Moving Average | $213.77(0.1%) | To recent high | -1.5% | To recent low | 10.7% | Market Cap | $37.205b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |